Abstract:Abstract As crucial antigen presenting cells, dendritic cells (DCs) play a vital role in tumor immunotherapy. Taking into account the many recent advances in DC biology, we discuss how DCs (1) recognize pathogenic antigens with pattern recognition receptors through specific phagocytosis and through non-specific micropinocytosis, (2) process antigens into small peptides with proper sizes and sequences, and (3) present MHC-peptides to CD4 + and CD8 + T cells to initiate immune responses against invading microbes and aberrant host cells. During anti-tumor immune responses, DC-derived exosomes were discovered to participate in antigen presentation. T cell microvillar dynamics and TCR conformational changes were demonstrated upon DC antigen presentation. Caspase-11-driven hyperactive DCs were recently reported to convert effectors into memory T cells. DCs were also reported to crosstalk with NK cells. Additionally, DCs are the most important sentinel cells for immune surveillance in the tumor microenvironment. Alongside DC biology, we review the latest developments for DC-based tumor immunotherapy in preclinical studies and clinical trials. Personalized DC vaccine-induced T cell immunity, which targets tumor-specific antigens, has been demonstrated to be a promising form of tumor immunotherapy in patients with melanoma. Importantly, allogeneic-IgG-loaded and HLA-restricted neoantigen DC vaccines were discovered to have robust anti-tumor effects in mice. Our comprehensive review of DC biology and its role in tumor immunotherapy aids in the understanding of DCs as the mentors of T cells and as novel tumor immunotherapy cells with immense potential.

Human dendritic cells in cancer

Progress on Dendritic Cell Vaccines in Tumor Immunotherapy

Dendritic cell subsets and implications for cancer immunotherapy

Exploring dendritic cell subtypes in cancer immunotherapy: unraveling the role of mature regulatory dendritic cells

Dendritic cells as orchestrators of anticancer immunity and immunotherapy

Dendritic Cells in Shaping Anti-Tumor T Cell Response

Human dendritic cell subsets: an update

Dendritic cell subsets in cancer immunity and tumor antigen sensing

The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.

Dendritic cell biology and its role in tumor immunotherapy

Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells

The role of dendritic cells in cancer immunity and therapeutic strategies

Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications

Immunobiology of dendritic cells.

Conventional type 1 dendritic cells (cDC1) in cancer immunity

Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity

Deciphering Tumor-Infiltrating Dendritic Cells in the Single-Cell Era

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens

Phenotypic and functional differences of dendritic cells in tumor

Progress in Biology of Dendritic Cells——Review

Relationship of Dendritic Cells and Tumor Immunity